Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Liabilities from Discontinued Operations: 2017-2023

Historic Liabilities from Discontinued Operations for Lifecore Biomedical (LFCR) over the last 2 years, with Feb 2023 value amounting to $518,000.

  • Lifecore Biomedical's Liabilities from Discontinued Operations fell 94.11% to $518,000 in Q1 2023 from the same period last year, while for Feb 2023 it was $518,000, marking a year-over-year decrease of 94.11%. This contributed to the annual value of $4.7 million for FY2022, which is 90.41% down from last year.
  • Per Lifecore Biomedical's latest filing, its Liabilities from Discontinued Operations stood at $518,000 for Q1 2023, which was down 96.92% from $16.8 million recorded in Q4 2022.
  • Lifecore Biomedical's Liabilities from Discontinued Operations' 5-year high stood at $66.5 million during Q4 2020, with a 5-year trough of $518,000 in Q1 2023.
  • Its 3-year average for Liabilities from Discontinued Operations is $29.4 million, with a median of $16.8 million in 2022.
  • Data for Lifecore Biomedical's Liabilities from Discontinued Operations shows a maximum YoY crashed of 94.11% (in 2023) over the last 5 years.
  • Over the past 4 years, Lifecore Biomedical's Liabilities from Discontinued Operations (Quarterly) stood at $66.5 million in 2020, then dropped by 6.08% to $62.4 million in 2021, then tumbled by 73.03% to $16.8 million in 2022, then tumbled by 94.11% to $518,000 in 2023.
  • Its last three reported values are $518,000 in Q1 2023, $16.8 million for Q4 2022, and $8.8 million during Q3 2022.